Gökben Koca
Chief Medical Officer Mariana Oncology
Dr. Gökben Koca is the Chief Medical Officer at Mariana Oncology, a Novartis subsidiary dedicated to developing novel radioligand therapies (RLTs) for treating cancers with high unmet needs. In her role, Dr. Koca oversees the translational/early clinical development of targeted peptide-based radiopharmaceuticals, aiming to transform cancer treatment by delivering effective and safe therapies. She will be presenting “The Mariana Story,” sharing insights into the company’s innovative approach to precision radiopharmaceuticals and their journey towards improving patient outcomes.
Seminars
• Story from conception to acquisition
• Innovative Precision RLTs expanding in solid tumor indications of high unmet need
• Showing first preclinical data
• Using real-world clinical outcomes to provide insights into patient populations, treatment efficacy and long-term safety
• Enhancing trial design through optimal patient selection, dosing strategies and endpoints
• Guiding potential personalized treatment strategies
